Earnings History Data for Kymera Therapeutics, Inc. (KYMR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kymera Therapeutics, Inc.

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
03-11-2022 PM 7:00 AM ET
(Nov 3)
KYMR Kymera Therapeutics, Inc. 1,640 -0.79 -0.70 -0.56 Kymera Therapeutics GAAP EPS of -$0.79 misses by $0.05, revenue of $9.54M misses by $6.4M
[11/3/2022 7:21 AM]
31.03 2.28 
(7.93%)
28.24 -0.51 
(-1.77%)
13.15 - 69.12 446,185 670,000 696
09-08-2022 PM 7:00 AM ET
(Aug 9)
KYMR Kymera Therapeutics, Inc. 1,120 -0.78 -0.68 -0.55 Kymera Therapeutics GAAP EPS of -$0.78 misses by $0.08, revenue of $11.51M misses by $3.46M
[8/9/2022 7:11 AM]
30.32 -1.11 
(-3.53%)
28.91 -2.52 
(-8.02%)
13.15 - 69.12 494,631 680,000 11,486
03-05-2022 PM 7:00 AM ET
(May 3)
KYMR Kymera Therapeutics 1,680 -0.71 -0.67 0.00 Kymera Therapeutics GAAP EPS of -$0.71 misses by $0.05, revenue of $9.62M misses by $9.04M
[5/3/2022 7:04 AM]
24.88 -7.85 
(-23.98%)
32.73 0.0 
(0.00%)
23.16 - 69.12 2,112,958 440,000 18,920
24-02-2022 PM 7:00 AM ET
(Feb 24)
KYMR Kymera Therapeutics 1,989 -0.66 -0.36 0.00 Kymera Therapeutics GAAP EPS of -$0.66 misses by $0.09, revenue of $15.27M misses by $6.04M
[2/24/2022 7:47 AM]
42.59 2.43 
(6.05%)
0.0 0.0 
(0.00%)
29.93 - 69.12 37,473 373,820 0
10-11-2021 PM KYMR Kymera Therapeutics 3,346 -0.56 -0.34 0.00 Kymera Therapeutics EPS misses by $0.11, beats on revenue
[11/10/2021 8:45 AM]
63.79 -1.77 
(-2.70%)
0.0 0.0 
(0.00%)
29.93 - 91.92 202,467 290,000 0
06-08-2021 PM KYMR Kymera Therapeutics, Inc. 3,000 -0.55 -0.21 0.00 Kymera Therapeutics EPS misses by $0.26, misses on revenue
[8/6/2021 7:29 AM]
59.41 -2.86 
(-4.59%)
63.00 0.73 
(1.17%)
25.43 - 91.92 288,197 330,000 214
06-05-2021 PM KYMR Kymera Therapeutics, Inc. 1,884 -0.29 -0.17 0.00 Kymera Therapeutics EPS misses by $0.14, misses on revenue
[5/6/2021 7:36 AM]
40.98 -0.26 
(-0.63%)
40.98 0.0 
(0.00%)
25.43 - 91.92 334,942 320,000 133
11-03-2021 PM KYMR Kymera Therapeutics, Inc. 2,140 -0.29 0.02 0.00 Kymera Therapeutics EPS misses by $0.12, misses on revenue
[3/11/2021 7:42 AM]
59.14 1.78 
(3.11%)
59.29 1.93 
(3.36%)
25.43 - 91.92 470,018 329,733 353